We are live on ! Find out more
DVC

Deer VII & Co Portfolio holdings

AUM $317M
1-Year Est. Return 30.89%
This Fund
S&P 500
This Quarter Est. Return
+34.06%
1 Year Est. Return
+30.89%
3 Year Est. Return
+241.3%
5 Year Est. Return
+1,036.06%
10 Year Est. Return
AUM
$67.5M
AUM Growth
Cap. Flow
+$58.7M
Cap. Flow %
86.86%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
TPST icon
Tempest Therapeutics
TPST
+$30.7M
2
VSTM icon
Verastem
VSTM
+$20M
3
INSM icon
Insmed
INSM
+$7.89M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPST icon
1
Tempest Therapeutics
TPST
$13.9M
$30.8M 45.62%
+818
New +$30.7M
VSTM icon
2
Verastem
VSTM
$547M
$27.7M 41.01%
+166,270
New +$20M
INSM icon
3
Insmed
INSM
$22.6B
$9.03M 13.37%
+772,240
New +$7.89M

Similar funds

Deer VII & Co's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Deer VII & Co, which disclosed 3 positions worth $67.5M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Tempest Therapeutics: 818 shares worth $30.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Deer VII & Co's largest Q2 2013 buy was Tempest Therapeutics: 818 shares worth $30.8M.
  • Deer VII & Co's ten largest holdings make up 100% of its $67.5M portfolio in Q2 2013.
  • Deer VII & Co disclosed 3 positions in Q2 2013, its first 13F filing on record.

Based on Deer VII & Co's 13F filing for Q2 2013, filed 14 Aug 2013.